SPDL1 and neoplasm: sPD-L1 concentrations at the first tumor evaluation were significantly higher in non-responders with a median value of 67.64 pg/mL (IQR 46.36–75.14) compared to 32.94 pg/mL (IQR 24.89–58.91) in responders (p = 0.031).